Effectiveness and safety of P2Y12 inhibitors in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: a nationwide registry-based study.
Sissel J GodtfredsenKristian H KragholmPeter LeutscherSteen Hylgaard JørgensenMartin Kirk ChristensenJawad H ButtGunnar Hilmar GislasonLars Valeur KøberEmil L FosbølMaurizio SessaDeepak L BhattChristian Torp-PedersenManan PareekPublished in: European heart journal. Acute cardiovascular care (2022)
Ticagrelor and prasugrel were associated with lower risks of MACE after STEMI than clopidogrel, and ticagrelor was associated with a marginal reduction compared with prasugrel. The risk of bleeding was lower with ticagrelor compared with clopidogrel, but did not significantly differ between ticagrelor and prasugrel.
Keyphrases
- percutaneous coronary intervention
- st segment elevation myocardial infarction
- acute coronary syndrome
- st elevation myocardial infarction
- antiplatelet therapy
- acute myocardial infarction
- coronary artery disease
- coronary artery bypass grafting
- atrial fibrillation
- coronary artery bypass
- cross sectional
- left ventricular
- climate change